Delisted! Generex Biotechnology Corp. (GNBT) Moving to Bulletin Boards; Files an Appeal
Generex Biotechnology received notice yesterday from the NASDAQ Listing Qualifications Panel that it has been determined to delist the Company’s common stock from the NASDAQ Capital Market and trading of the stock will be suspended as of the open on Thursday, October 21, 2010 as a result of non-compliance with the minimum $1.00 per share closing bid price requirement for continued listing on the NASDAQ CM. Generex will retain its ticker symbol of GNBT and begin trading and listing on the OTCBB through the OTCQB tier of Pink OTC Markets, Inc. Real time stock quotes for GNBT will be available…